Search research articles
Contact Us
Filters
Showing results (181-190 of 466) with videos related to
Page
of 47
Sort By:
AIDS Research and Human Retroviruses
|
September 13, 2016
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy
Leonardo Calza, Vincenzo Colangeli, Eleonora Magistrelli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 22, 2022
The impact of preservation fluid culture on graft site arteritis: A systematic review and meta-analysis
Matteo Rinaldi, Cecilia Bonazzetti, Milo Gatti, et al.
HIV Clinical Trials
|
January 6, 2016
Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Leonardo Calza, Ilaria Danese, Eleonora Magistrelli, et al.
International Journal of Antimicrobial Agents
|
October 14, 2023
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)
Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, et al.
The Pediatric Infectious Disease Journal
|
July 31, 2023
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative Infections
Milo Gatti, Caterina Campoli, Maria Elena Latrofa, et al.
Le Infezioni in Medicina
|
March 22, 2014
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infection
Lucia Appolloni, Federica Locchi, Nicolò Girometti, et al.
AIDS Research and Human Retroviruses
|
November 5, 2014
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study
Leonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
Antibiotics (Basel, Switzerland)
|
June 2, 2021
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018
Paolo Gaibani, Donatella Lombardo, Linda Bussini, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
June 29, 2023
Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement
Andrea Cortegiani, Massimo Antonelli, Marco Falcone, et al.
Jac-Antimicrobial Resistance
|
June 18, 2026
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
Emre Yücel, Alex Soriano, Florian Thalhammer, et al.
Page
of 47
Search research articles
Search
Showing results (181-190 of 466) with videos related to
Sort By:
Page
of 47
AIDS Research and Human Retroviruses
|
September 13, 2016
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy
Leonardo Calza, Vincenzo Colangeli, Eleonora Magistrelli, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 22, 2022
The impact of preservation fluid culture on graft site arteritis: A systematic review and meta-analysis
Matteo Rinaldi, Cecilia Bonazzetti, Milo Gatti, et al.
HIV Clinical Trials
|
January 6, 2016
Dual Raltegravir-Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Leonardo Calza, Ilaria Danese, Eleonora Magistrelli, et al.
International Journal of Antimicrobial Agents
|
October 14, 2023
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)
Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, et al.
The Pediatric Infectious Disease Journal
|
July 31, 2023
Relationship Between Real-time TDM-guided Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam Monotherapy and Microbiologic Outcome in the Treatment of Critically Ill Children With Severe Documented Gram-negative Infections
Milo Gatti, Caterina Campoli, Maria Elena Latrofa, et al.
Le Infezioni in Medicina
|
March 22, 2014
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infection
Lucia Appolloni, Federica Locchi, Nicolò Girometti, et al.
AIDS Research and Human Retroviruses
|
November 5, 2014
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study
Leonardo Calza, Ilaria Danese, Vincenzo Colangeli, et al.
Antibiotics (Basel, Switzerland)
|
June 2, 2021
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018
Paolo Gaibani, Donatella Lombardo, Linda Bussini, et al.
Journal of Anesthesia, Analgesia and Critical Care
|
June 29, 2023
Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement
Andrea Cortegiani, Massimo Antonelli, Marco Falcone, et al.
Jac-Antimicrobial Resistance
|
June 18, 2026
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study
Emre Yücel, Alex Soriano, Florian Thalhammer, et al.
Page
of 47